AstraZeneca’s Antibody Combination Authorized for Use in Great Britain for Prevention of COVID-19

AstraZeneca’s antibody combination has been authorized for use in Great Britain to prevent COVID-19 in high-risk populations and people for whom vaccination may not be effective.